Department of Surgery, University Hospital of Bonn, Bonn, Germany; Department of Hepatobiliary Pancreatic Surgery and Transplantation, Kyoto University Hospital, Kyoto, Japan.
Department of Surgery, University Hospital of Bonn, Bonn, Germany.
Transplant Rev (Orlando). 2019 Jul;33(3):173-181. doi: 10.1016/j.trre.2019.04.001. Epub 2019 Apr 11.
Intestinal transplantation (ITX) constitutes a salvage treatment for irreversible intestinal failure and failure of parenteral nutrition. Chronic rejection (CR) remains the key obstacle for long-term intestinal graft survival but the pathomechanisms are incompletely understood. This study systematically reviews experimental models addressing CR after ITX in order to summarize current knowledge on CR pathogenesis and identify promising experimental strategies. A systematic literature search was conducted in line with the PRISMA guidelines, and 68 out of 677 articles qualified for the final analysis. The average methodological quality of the studies was suboptimal with 7 out of 11 points as assessed by a modified Oxford Centre for Evidence-Based Medicine score. Histology of the chronically rejected graft was almost universally integrated as outcome parameter but we found significant heterogeneity in utilized transplant techniques, organ preservation, immunosuppression and time points of CR-assessment. Several studies identified cellular and humoral immunologic mechanisms in chronic intestinal rejection. Yet, neither preventive nor therapeutic strategies against CR have been successfully introduced into human intestinal transplantation highlighting the persistent need for optimized experimental models. In this review, we aim to improve the translational value of forthcoming investigations on CR by discussing the experimental status quo and potential innovative approaches.
肠移植(ITX)是治疗不可逆转的肠衰竭和肠外营养失败的一种挽救性治疗方法。慢性排斥反应(CR)仍然是长期肠移植物存活的关键障碍,但发病机制尚不完全清楚。本研究系统地回顾了 ITX 后针对 CR 的实验模型,以总结目前对 CR 发病机制的认识,并确定有前途的实验策略。根据 PRISMA 指南进行了系统的文献检索,最终有 68 篇文章符合分析要求。通过改良的牛津循证医学中心评分,11 分中有 7 分,研究的方法学质量平均较低。慢性排斥反应移植的组织学几乎普遍被纳入为结局参数,但我们发现,所使用的移植技术、器官保存、免疫抑制和 CR 评估的时间点存在显著的异质性。一些研究确定了慢性肠道排斥反应中的细胞和体液免疫机制。然而,针对 CR 的预防或治疗策略尚未成功引入人类肠移植,这突出表明需要优化实验模型。在这篇综述中,我们旨在通过讨论实验现状和潜在的创新方法,提高未来对 CR 研究的转化价值。